NCT02523612View on ClinicalTrials.gov

Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 24, 2015

Primary Completion Date

June 25, 2018

Study Completion Date

June 25, 2018

Conditions
Breast Cancer
Interventions
PROCEDURE

Biopsy

PROCEDURE

Blood sample

Trial Locations (1)

94805

Gustave Roussy Cancer Campus Grand Paris, Villejuif

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT02523612 - Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions | Biotech Hunter | Biotech Hunter